#news #biotech BTI files for $69M IPO to run trials in Alzheimer’s and cancer

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: BTI files for $69M IPO to run trials in Alzheimer’s and cancer .BioXcel Therapeutics (BTI) has filed to raise $69 million through a Nasdaq IPO. BTI will spend … Continue reading →

Cet article #news #biotech BTI files for $69M IPO to run trials in Alzheimer’s and cancer est apparu en premier sur Biotech 365.

Original Article: #news #biotech BTI files for $69M IPO to run trials in Alzheimer’s and cancer

More From BioPortfolio on "#news #biotech BTI files for $69M IPO to run trials in Alzheimer’s and cancer"